Chlortalidone and bumetanide in advanced chronic kidney disease: HEBE-CKD Trial

30 August 2020 (11:03 - 11:11)
Organised by:
Congress Presentation Part of: Challenges in Hypertension Management Pharmacotherapy ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by